SSTR2 and Hypoglycemia: Previous experiments in our lab assessing hypoglycemia prevention using an SSTR2 antagonist in a rodent model of recurrent hypoglycemia have also demonstrated a similar decrease in liver glycogen content with drug treatment (Hoffman et al., 2021).